Assyro AI

Orange Book product · Brand (NDA)

ANTARA (MICRONIZED)

FENOFIBRATE

Brand (NDA)NDA 021695DISCN LUPIN

At a glance

Oct 18, 2013

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 18, 2013

    12 yr 10 mo ago

  2. Today

  3. Patent 9314447 expires

    Listed drug product patent expiration.

    May 31, 2033

    in 7 yr 1 mo

  4. Patent 9314447 expires

    Listed drug product patent expiration.

    May 31, 2033

    in 7 yr 1 mo

Pharmaceutical detail

Active ingredient

FENOFIBRATE

Strength

90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

NDA 021695

Product number

005

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9314447May 31, 2033in 7 yr 1 mo
ProductU-1447
9314447May 31, 2033in 7 yr 1 mo
ProductU-1448
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.